GlassScriptPhysician profile
Angela S Collier
NPI 1255654257
$1,069.27
in general payments reported to CMS, 2019-2025
21 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $40.95 · 2021: $17.59 · 2022: $177 · 2023: $150 · 2024: $171 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $170.19 | 2021-2025 | |
| Astellas Pharma US INC | $139.84 | 2023-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $98.26 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $89.64 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.04 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $84.06 | 2025 | Myfembree |
| Optumhealth Care Solutions, LLC | $50.23 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pfizer INC. | $49.01 | 2019-2022 | |
| Agile Therapeutics, INC. | $43.87 | 2022-2024 | Twirla |
| Organon LLC | $42.37 | 2022-2025 | Jada System |
| Amgen INC. | $31.17 | 2019-2020 | |
| Evofem Biosciences, INC. | $28.64 | 2022 | |
| Merck Sharp & Dohme LLC | $26.05 | 2019 | |
| Myovant Sciences INC. | $23.04 | 2022 | |
| Solventum Corporation | $19.89 | 2025 | Prevena |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.32 | 2025 | Mounjaro |
| Lsi Solutions INC | $16.80 | 2023 | Ti Knot, Fornisee, Running Device |
| Millicent US INC | $15.12 | 2025 | Femlyv |
| Daiichi Sankyo INC. | $15.10 | 2020 | |
| Scynexis, INC. | $12.11 | 2022 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.